Zobrazeno 1 - 10
of 47
pro vyhledávání: '"Tianna Zhao"'
Autor:
Gary L. Gallia, Ming Zhang, Yi Ning, Michael C. Haffner, Denise Batista, Zev A. Binder, Justin A. Bishop, Christine L. Hann, Ralph H. Hruban, Masaru Ishii, Alison P. Klein, Douglas D. Reh, Lisa M. Rooper, Vafi Salmasi, Rafael J. Tamargo, Qing Wang, Tara Williamson, Tianna Zhao, Ying Zou, Alan K. Meeker, Nishant Agrawal, Bert Vogelstein, Kenneth W. Kinzler, Nickolas Papadopoulos, Chetan Bettegowda
Publikováno v:
Nature Communications, Vol 9, Iss 1, Pp 1-6 (2018)
Olfactory neuroblastoma (ONB) is a rare malignant tumor whose genetic basis is poorly understood. Here the authors identify recurrent deletions involving dystrophin in the majority of ONB patient tumors examined.
Externí odkaz:
https://doaj.org/article/666203899eb144b58109b82017f4bbe7
Autor:
Riccardo Serra, Tianna Zhao, Sakibul Huq, Noah Leviton Gorelick, Joshua Casaos, Arba Cecia, Antonella Mangraviti, Charles Eberhart, Renyuan Bai, Alessandro Olivi, Henry Brem, Eric M. Jackson, Betty Tyler
Publikováno v:
PLoS ONE, Vol 16, Iss 11 (2021)
Background Medulloblastoma (MB) is the most common brain malignancy in children, and is still responsible for significant mortality and morbidity. The aim of this study was to assess the safety and efficacy of Disulfiram (DSF), an FDA-approved inhibi
Externí odkaz:
https://doaj.org/article/f8cb841dda8541a1b7d69527798e1470
Autor:
John Choi, Ravi Medikonda, Laura Saleh, Timothy Kim, Ayush Pant, Siddhartha Srivastava, Young-Hoon Kim, Christina Jackson, Luqing Tong, Denis Routkevitch, Christopher Jackson, Dimitrios Mathios, Tianna Zhao, Hyerim Cho, Henry Brem, Michael Lim
Publikováno v:
OncoImmunology, Vol 10, Iss 1 (2021)
Clinical trials involving anti-programmed cell death protein-1 (anti-PD-1) failed to demonstrate improved overall survival in glioblastoma (GBM) patients. This may be due to the expression of alternative checkpoints such as B- and T- lymphocyte atten
Externí odkaz:
https://doaj.org/article/fec2149312214561bd09fa9ce33ca8b7
Publikováno v:
Mathematics, Vol 10, Iss 11, p 1847 (2022)
Multi-label classification deals with the determination of instance-label associations for unseen instances. Although many margin-based approaches are delicately developed, the uncertainty classifications for those with smaller separation margins rem
Externí odkaz:
https://doaj.org/article/d22b79c8c1fa4b61aad8c48e6e11d253
Publikováno v:
Mathematics, Vol 10, Iss 11, p 1871 (2022)
Data representation is of significant importance in minimizing multi-label ambiguity. While most researchers intensively investigate label correlation, the research on enhancing model robustness is preliminary. Low-quality data is one of the main rea
Externí odkaz:
https://doaj.org/article/0b4461ea2f854c519edd08df9ea9ca84
Autor:
Tianna Zhao, Herma Zondervan-van der Linde, Lies-Anne Severijnen, Ben A Oostra, Rob Willemsen, Vincenzo Bonifati
Publikováno v:
PLoS ONE, Vol 7, Iss 11, p e48911 (2012)
Recessive mutations in the F-box only protein 7 gene (FBXO7) cause PARK15, a mendelian form of early-onset, levodopa-responsive parkinsonism with severe loss of nigrostriatal dopaminergic neurons. However, the function of the protein encoded by FBXO7
Externí odkaz:
https://doaj.org/article/27a81de30a274fc8b9975f9748f1fc7c
Autor:
Tianna Zhao, Esther De Graaff, Guido J Breedveld, Agnese Loda, Lies-Anne Severijnen, Cokkie H Wouters, Frans W Verheijen, Marieke C J Dekker, Pasquale Montagna, Rob Willemsen, Ben A Oostra, Vincenzo Bonifati
Publikováno v:
PLoS ONE, Vol 6, Iss 2, p e16983 (2011)
Mutations in the F-box only protein 7 gene (FBXO7) cause PARK15, an autosomal recessive neurodegenerative disease presenting with severe levodopa-responsive parkinsonism and pyramidal disturbances. Understanding the PARK15 pathogenesis might thus pro
Externí odkaz:
https://doaj.org/article/79ff1dcbf60b48248d53e36d35d1a7d6
Publikováno v:
International Journal of Approximate Reasoning. 150:172-187
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::e173d287d4a025ae6d77a943b30ebc09
https://doi.org/10.1016/j.ijar.2022.08.008
https://doi.org/10.1016/j.ijar.2022.08.008
Autor:
Betty Tyler, Nicolas Skuli, Henry Brem, Mariana Brait, David Sidransky, Ian Suk, Chenchen Ji, Arba Cecia, Alexander Perdomo-Pantoja, Wataru Ishida, Tianna Zhao, Noah L. Gorelick, Manuel Morales, Jayanidhi N. Kedda, Jeff Ehresman, Andy S. Ding, Yuanxuan Xia, Michael Peters, Riccardo Serra, Joshua Casaos, Sakibul Huq
Nasopharyngeal carcinoma (NPC) is a squamous cell carcinoma with a proclivity for systemic dissemination, leading many patients to present with advanced stage disease and fail available treatments. There is a notable lack of targeted therapies for NP
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4c2e680509b924f5a91b3a887389995f
https://doi.org/10.1158/1535-7163.c.6542772.v1
https://doi.org/10.1158/1535-7163.c.6542772.v1
Autor:
Betty Tyler, Nicolas Skuli, Henry Brem, Mariana Brait, David Sidransky, Ian Suk, Chenchen Ji, Arba Cecia, Alexander Perdomo-Pantoja, Wataru Ishida, Tianna Zhao, Noah L. Gorelick, Manuel Morales, Jayanidhi N. Kedda, Jeff Ehresman, Andy S. Ding, Yuanxuan Xia, Michael Peters, Riccardo Serra, Joshua Casaos, Sakibul Huq
Supplementary Figures 1-6
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1e270d2a7aba9e01c105640312e2ae1a
https://doi.org/10.1158/1535-7163.22520778.v1
https://doi.org/10.1158/1535-7163.22520778.v1